In Vitro Antimicrobial Activity of Chlorhexidine–Curcumin Nanoformulations for Teat Dipping Against Mastitis Pathogens
Authors:
- Areerat ChuasakhonwilaiACAreerat Chuasakhonwilai
- Wasana ChaisriWasana Chaisri
- Montira IntanonMIMontira Intanon
- Duanghathai SaipintaDSDuanghathai Saipinta
- Patsorn KeeklangdonPKPatsorn Keeklangdon
- Pimnipa JieraviriyapunPJPimnipa Jieraviriyapun
- Sho NakamuraSNSho Nakamura
- Satoshi OhkuraSOSatoshi Ohkura
- Witaya SuriyasathapornWSWitaya Suriyasathaporn
Open Access
- 8 October 2026
- journal article
- research article
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (10) , 1054
Abstract
Bovine mastitis is a major problem affecting dairy production, and teat disinfection is important for reducing the risk of bacterial infection. Curcumin has antimicrobial properties, but its poor water solubility limits its use in aqueous formulations. This study aimed to develop chlorhexidine–curcumin nanoformulations (CCNs) and perform preliminary in vitro screening of these nanoformulations as candidate teat-dipping formulations. Four CCNs containing increasing concentrations of curcumin (0%, 0.1%, 0.5%, and 0.9% w/v; CCN0, CCN0.1, CCN0.5, and CCN0.9, respectively) were prepared. CCN0, CCN0.1, and CCN0.5 were formulated as oil-in-water nanoemulsions, whereas CCN0.9 was prepared as a curcumin-β-cyclodextrin inclusion complex. The physicochemical properties were characterized, and the antibacterial activity was evaluated in vitro by agar well diffusion against six mastitis-associated pathogens. CCN0.9 showed the largest inhibition zones overall (20.07 ± 1.05–28.85 ± 1.05 mm; p < 0.05), while CCN0.1 and CCN0.5 showed activity comparable to or greater than that of commercial teat dips against several pathogens. CCN0.5 showed the most favorable nanoemulsion characteristics, with a particle size of 94.77 nm and a zeta potential of −46.57 mV. Overall, CCNs demonstrated antibacterial activity against mastitis pathogens, supporting their potential as candidate teat-dip formulations. Further teat irritation and in vivo efficacy studies are needed before field application.Keywords
Funding Information
- Japan Society for the Promotion of Science (24K09263)
This publication has 44 references indexed in Scilit:
- Characterization of Nanoemulsion: Particle Size, Polydispersity Index, Zeta Potential, Thermal Stability, and Kinetic Stability2025
- Susceptibility of mastitis-causing pathogens (Escherichia coli and Staphylococcus aureus) to disinfectants used as teat dippingVeterinary Microbiology, 2025
- Chlorhexidine combined with curcumin-mediated photodynamic treatment effectively inhibits biofilm formation by clinical Candida isolates from the oral cavityPhotodiagnosis and Photodynamic Therapy, 2025
- Antimicrobial Nanoemulsion: A futuristic approach in antibacterial drug delivery systemJournal of Saudi Chemical Society, 2024
- Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailabilityJournal of the Science of Food and Agriculture, 2021
- Atopic dermatitisThe Lancet, 2020
- The Essential Medicinal Chemistry of CurcuminJournal of Medicinal Chemistry, 2017
- Methods for in vitro evaluating antimicrobial activity: A reviewJournal of Pharmaceutical Analysis, 2016
- Preparation and characterization of nanoemulsion encapsulating curcuminFood Hydrocolloids, 2015
- epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in EnglandJournal of Hospital Infection, 2007